Institute of Women's Life Medical Science, Women's Cancer Clinic, Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, South Korea.
BMC Med Genomics. 2012 May 29;5:18. doi: 10.1186/1755-8794-5-18.
Cancer stem cells (CSCs) are thought to be a source of tumor recurrence due to their stem cell-like properties. MicroRNAs (miRNAs) regulate both normal stem cells and CSCs, and dysregulation of miRNAs has an important role in tumorigenesis. Cluster of differentiation (CD) 133(+) and spheroid formation have been reported to be one of the main features of ovarian CSCs. Therefore, we determined the miRNA expression profile of a CD133(+) spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line.
Initially, we confirmed the enrichment of the OVCAR3 CD133 subpopulation by evaluating in vitro anchorage-independent growth. After obtaining a subpopulation of CD133(+) OVCAR3 cells with > 98% purity via cell sorting, miRNA microarray and real-time reverse transcription-polymerase chain reaction (RT-PCR) were performed to evaluate its miRNA profile.
We found 37 differentially expressed miRNAs in the CD133(+) spheroid-forming subpopulation of OVCAR3 cells, 34 of which were significantly up-regulated, including miR-205, miR-146a, miR-200a, miR-200b, and miR-3, and 3 of which were significantly down-regulated, including miR-1202 and miR-1181.
Our results indicate that dysregulation of miRNA may play a role in the stem cell-like properties of ovarian CSCs.
癌症干细胞(CSCs)被认为是肿瘤复发的根源,因为它们具有干细胞样特性。微小 RNA(miRNA)调节正常干细胞和 CSCs,miRNA 的失调在肿瘤发生中起着重要作用。CD133(+)和球体形成已被报道为卵巢 CSCs 的主要特征之一。因此,我们确定了 OVCAR3 人卵巢癌细胞系 CD133(+)球体形成亚群的 miRNA 表达谱。
最初,我们通过评估体外无锚定依赖性生长来证实 OVCAR3 CD133 亚群的富集。通过细胞分选获得纯度>98%的 CD133(+) OVCAR3 细胞亚群后,进行 miRNA 微阵列和实时逆转录聚合酶链反应(RT-PCR)以评估其 miRNA 谱。
我们在 OVCAR3 细胞的 CD133(+)球体形成亚群中发现了 37 个差异表达的 miRNA,其中 34 个显著上调,包括 miR-205、miR-146a、miR-200a、miR-200b 和 miR-3,3 个显著下调,包括 miR-1202 和 miR-1181。
我们的结果表明,miRNA 的失调可能在卵巢 CSCs 的干细胞样特性中发挥作用。